Design Therapeutics (DSGN) Net Equity Issued and Repurchased (2020 - 2026)
Design Therapeutics (DSGN) reported Net Equity Issued and Repurchased of $19.9 million for Q1 2026, up 115.36% sequentially from -$129.6 million in Q2 2021.
Design Therapeutics (DSGN) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
Design Therapeutics (DSGN) has 3 years of Net Equity Issued and Repurchased data on file, last reported at $19.9 million in Q1 2026.
- For the quarter ending Q1 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $19.9 million; the trailing twelve-month figure through Mar 2026 stood at $19.9 million (changed N/A YoY), and the FY2025 full-year result was $24.8 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased improved to $19.9 million in Q1 2026, from -$129.6 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $19.9 million in Q1 2026 to a low of $19.9 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 163.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 141.90 Mn |
| 10 | Design Therapeutics | 714.48 Mn | 491.66 Mn | - | 19.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.91 Mn |
| Mar 31, 2026 | 19.91 Mn |
| Jun 30, 2021 | -129.59 Mn |
| Jun 30, 2021 | -129.59 Mn |
| Mar 31, 2021 | 254.30 Mn |
| Mar 31, 2021 | 254.30 Mn |
| Jun 30, 2020 | 31,000.00 |
| Jun 30, 2020 | 31,000.00 |
| Mar 31, 2020 | 44.70 Mn |
| Mar 31, 2020 | 44.70 Mn |